1-[(4-甲基苯基)磺酰]-1H-吲哚-3-甲醛 | 50562-79-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-[(4-甲基苯基)磺酰]-1H-吲哚-3-甲醛
• 中文别名: 1-[(4-甲基苯基)磺酰基]-1H-吲哚-3-甲醛
• 英文名称: 1-(4-tolylsulfonyl)indole-3-carboxaldehyde
• 英文别名: N-tosylindole-3-carboxaldehyde；1-tosyl-1H-indole-3-carbaldehyde；1-[(4-methylphenyl)sulfonyl]-1H-indole-3-carbaldehyde；1-(4-methylphenyl)sulfonylindole-3-carbaldehyde
• CAS: 50562-79-3
• 化学式: C₁₆H₁₃NO₃S
• mdl: MFCD00238944
• 分子量: 299.35
• InChiKey: OIPHRFQIBIQGJF-UHFFFAOYSA-N

物化性质

• 熔点：
  138 °C
• 沸点：
  517℃
• 密度：
  1.28
• 闪点：
  267℃
• 溶解度：
  <0.6 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.062
• 拓扑面积：
  64.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 安全说明：
  S24/25
• 海关编码：
  2933990090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  | 2-8°C |

SDS

Name:	1-[(4-Methylphenyl)sulfonyl]-1H-indole-3-carbaldehyde 97% Material Safety Data Sheet
Synonym:
CAS:	50562-79-3

Section 1 - Chemical Product MSDS Name:1-[(4-Methylphenyl)sulfonyl]-1H-indole-3-carbaldehyde 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
50562-79-3	1-[(4-Methylphenyl)sulfonyl]-1H-indole	97%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 50562-79-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: tan
Odor: odorless - slight odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 151 - 152 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C16H13NO3S
Molecular Weight: 299

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 50562-79-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-[(4-Methylphenyl)sulfonyl]-1H-indole-3-carbaldehyde - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 50562-79-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 50562-79-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 50562-79-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-[(4-甲基苯基)磺酰]-1H-吲哚-3-甲醛 在 RuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh) 、 盐酸 、 titanium(IV) tetraethanolate 、 indium 、 magnesium 、 N,N-二异丙基乙胺 、 三苯基膦 、 三氟乙酸 、 偶氮二甲酸二乙酯 作用下， 以 1,4-二氧六环 、 甲醇 、 二氯甲烷 、 水 、 甲苯 为溶剂， 反应 12.0h， 生成 methyl (3aS,6aR,11bR)-2,3,3a,4,6a,7-hexahydro-1H-pyrrolo[2,3-d]carbazole-6-carboxylate
  参考文献：
  名称：

  （-）-葡糖苷A，B和F，（-）-棘氨idine碱和（-）-N-脱甲基algugucine的总合成

  摘要：

  摘要 报道了（-）-葡糖苷A，B和F，（-）-衣他m和（-）- N-脱甲基alusgucine的首次对映选择性合成。这篇文章详细介绍了我们的第一代和第二代方法对马兜铃生物碱的ABCE四环核心的发展及其在上述目标中的应用。关键步骤涉及我们的顺序一锅双环化方法，该方法构建了四环核的C和E环，以及Rawal在分子内Heck反应中的应用，以确保所有目标中共有的五环骨架。 报道了（-）-葡糖苷A，B和F，（-）-衣他m和（-）- N-脱甲基alusgucine的首次对映选择性合成。这篇文章详细介绍了我们的第一代和第二代方法对马兜铃生物碱的ABCE四环核心的发展及其在上述目标中的应用。关键步骤涉及我们的顺序一锅双环化方法，该方法构建了四环核的C和E环，以及Rawal在分子内Heck反应中的应用，以确保所有目标中共有的五环骨架。

  DOI：

  10.1055/s-0034-1378698
• 作为产物：
  描述：

  N-((1-tosyl-1H-indol-3-yl)methyl)aniline 在 碘苯二乙酸 作用下， 以 甲苯 为溶剂， 生成 1-[(4-甲基苯基)磺酰]-1H-吲哚-3-甲醛
  参考文献：
  名称：

  苯并碘（III）双乙酸盐介导的咪唑并[1,2-a]吡啶的曼尼希碱中的1,2-异丙基迁移：N-乙酰氧基甲基/烷氧基甲基-N-芳基咪唑并[1,2-a]吡啶-3-的制备胺类。

  摘要：

  Phenyliodine（III）二乙酸介导的1,2-本位的咪唑并-migration [1,2一]吡啶通过从咪唑衍生的形成氮丙啶的中间体在曼尼希碱环[1,2一]吡啶，2-据报道有吡啶胺或芳胺，以及甲醛。的咪唑并[1,2一]吡啶轴承不同的取代基表现出极好的迁移性，并导致对应Ñ -acetoxymethyl-，Ñ -alkoxymethyl-和Ñ羟基甲基Ñ -arylimidazo [1,2一]吡啶-3-胺衍生物的产率为中度至优异（42例； 35-93％）。自由基捕获实验证实了非自由基中间体的参与。所开发的方案适合扩大规模的反应，并且通过将N-乙酰氧基甲基产物转化为相应的N-（吡啶-2-基）咪唑并[1,2 - a ]吡啶-3-胺来证明其合成实用性。

  DOI：

  10.1021/acs.joc.0c00674

文献信息

• Hydrazines and Azides via the Metal-Catalyzed Hydrohydrazination and Hydroazidation of Olefins
  作者：Jérôme Waser、Boris Gaspar、Hisanori Nambu、Erick M. Carreira

  DOI：10.1021/ja062355+

  日期：2006.9.1

  which the H and the N atoms come from two different reagents, a silane and an oxidizing nitrogen source (azodicarboxylate or sulfonyl azide). The hydrohydrazination reaction using di-tert-butyl azodicarboxylate is characterized by its ease of use, large functional group tolerance, and broad scope, including mono-, di-, tri-, and tetrasubstituted olefins. Key to the development of the hydroazidation

  报道了 Co 和 Mn 催化的烯烃加氢肼和加氢叠氮化反应的发现、研究和实施。这些反应等效于 CC 双键与受保护的肼或偶氮酸的直接加氢胺化，但基于不同的概念，其中 H 和 N 原子来自两种不同的试剂，硅烷和氧化性氮源（偶氮二羧酸或磺酰叠氮化物） ）。使用偶氮二羧酸二叔丁酯的加氢肼反应具有使用方便、官能团耐受性大、适用范围广的特点，包括单、二、三和四取代烯烃。氢叠氮化反应发展的关键是使用磺酰叠氮化物作为氮源和叔丁基过氧化氢的活化作用。发现该反应对于单、二和三取代烯烃的官能化是有效的，并且只有少数官能团是不能容忍的。获得的烷基叠氮化物是通用中间体，可以在不分离叠氮化物的情况下转化为游离胺或三唑。初步的机理研究表明，烯烃的氢化钴是限速的，然后是胺化反应。不能排除并可能涉及自由基中间体。然后进行胺化反应。不能排除并可能涉及自由基中间体。然后进行胺化反应。不能排除并可能涉及自由基中间体。
• Iridium(<scp>iii</scp>) catalyzed regioselective amidation of indoles at the C4-position using weak coordinating groups
  作者：Veeranjaneyulu Lanke、Kandikere Ramaiah Prabhu

  DOI：10.1039/c7cc00763a

  日期：——

  Herein we disclose a simple and short synthetic route for the amidation of indoles at the C4 position by employing an aldehyde as a directing group and Ir(III) as a catalyst. This strategy offers high selectivity for the C4-amidation of unprotected and protected indoles. A simple deprotection of the tosyl group leads to the formation of C4-amino indole derivatives, which are useful synthons for synthesizing

  在几种天然产物和生物活性化合物中经常遇到C4胺化的吲哚支架。本文中，我们公开了通过使用醛作为导向基团和Ir（III）作为催化剂来使吲哚在C4位酰胺化的简单且短的合成路线。该策略为未保护的和被保护的吲哚的C4酰胺化提供了高选择性。甲苯磺酰基的简单脱保护导致形成C 4-氨基吲哚衍生物，其是用于合成调心素家族中的天然产物的有用的合成子。
• Palladium Catalyzed Regioselective C4‐Arylation and Olefination of Indoles and Azaindoles
  作者：Neetipalli Thrimurtulu、Arnab Dey、Anurag Singh、Kuntal Pal、Debabrata Maiti、Chandra M. R. Volla

  DOI：10.1002/adsc.201801378

  日期：2019.3.15

  A convergent strategy for the synthesis of biologically relevant C4‐substituted indole scaffolds was demonstrated using Pd(II)‐catalyzed remote C−H functionalization of indoles and azaindoles. The reaction displays high regioselectivity for the C4‐position of indole‐3‐carbaldehydes using glycine as an inexpensive transient directing group. Notable features of this transformation include the selective

  使用Pd（II）催化的吲哚和氮杂吲哚的远程CH功能化，证明了生物相关的C4取代的吲哚支架合成的收敛策略。该反应使用甘氨酸作为廉价的瞬态导向基团，对吲哚-3-甲醛的C4位具有很高的区域选择性。该转变的显着特征包括六元palladacyle的选择性形成和出色的官能团耐受性。
• Highly Enantioselective Iridium-Catalyzed Coupling Reaction of Vinyl Azides and Racemic Allylic Carbonates
  作者：Min Han、Min Yang、Rui Wu、Yang Li、Tao Jia、Yuanji Gao、Hai-Liang Ni、Ping Hu、Bi-Qin Wang、Peng Cao

  DOI：10.1021/jacs.0c01766

  日期：2020.8.5

  The Iridium-catalyzed enantioselective coupling reaction of vinyl azides and allylic electrophiles is presented and provides access to β-chiral carbonyl derivatives. Vinyl azide are used as acetamide enolate or acetonitrile carbanion surrogates, leading to γ,δ-unsaturated β-substituted amides as well as nitriles with excellent enantiomeric excess. The products are readily transformed into chiral N-containing

  介绍了铱催化的叠氮化乙烯基和烯丙基亲电试剂的对映选择性偶联反应，并提供了获得 β-手性羰基衍生物的途径。乙烯基叠氮化物用作乙酰胺烯醇化物或乙腈碳负离子替代物，导致 γ,δ-不饱和 β-取代酰胺以及具有优异对映体过量的腈。这些产品很容易转化为手性含氮积木和药物。提出了一种机制来合理化这种偶联反应的化学选择性。
• Transient Directing Group Strategy as a Unified Method for Site Selective Direct C4–H Halogenation of Indoles
  作者：Guanghua Kuang、Dandan Liu、Xuerong Chen、Guangyuan Liu、Yang Fu、Yiyuan Peng、Hua Li、Yirong Zhou

  DOI：10.1021/acs.orglett.1c03131

  日期：2021.11.5

  A unified method for direct C4–H halogenation of indoles has been accomplished with the assistance of anthranilic acids as suitable transient directing groups. Exclusive site selectivity (one out of five potential reactive sites) as well as good functional group tolerance was obtained to install three kinds of halogen atoms (Cl, Br and I, respectively) by using inexpensive N-halosuccinimides (NXS)

  在邻氨基苯甲酸作为合适的瞬态导向基团的帮助下，实现了吲哚直接 C4-H 卤化的统一方法。通过使用廉价的N-卤代琥珀酰亚胺 (NXS) 作为卤素源，在以下条件下获得了独家的位点选择性（五分之一的潜在反应位点）以及良好的官能团耐受性来安装三种卤素原子（分别为 Cl、Br 和 I）条件温和。利用产物中丰富的官能团，通过一步后期推导，轻松构建了多种含氮杂环。